Nephrogenic Adenoma of the Urethra: Diagnosis and Management
For nephrogenic adenoma (nephrogenic metaplasia) of the urethra, diagnosis requires cystoscopic visualization with biopsy to confirm histopathology and rule out malignancy, followed by transurethral resection for symptomatic lesions, with long-term surveillance mandatory due to high recurrence rates.
Diagnostic Approach
Initial Evaluation
When nephrogenic adenoma is suspected in the urethra, perform thorough cystoscopic examination of the entire urethra and bladder documenting tumor size, location, configuration, number, and mucosal abnormalities 1. The lesion typically presents with:
- Hematuria (most common presenting symptom) 2, 3
- Dysuria or urethral irritative symptoms 2, 3
- Urinary frequency and bladder pain 3
- May be asymptomatic and found incidentally in up to 39% of cases 3
Key Clinical Context
Look specifically for prior urothelial trauma history - present in 87% of cases 3:
- Previous urethral catheterization or instrumentation
- Prior urethral reconstruction or hypospadias repair 4
- History of urinary tract infections 2
- Previous urological surgeries 5
Biopsy is Mandatory
Biopsy is essential because nephrogenic adenoma can grossly mimic transitional cell carcinoma or clear cell adenocarcinoma 4. This is a critical diagnostic pitfall - on frozen section, nephrogenic adenoma has been misdiagnosed as squamous cell carcinoma due to variable architectural patterns, inflammation, and reactive changes 6. When malignancy is suspected on frozen section, obtain a second opinion from a genitourinary pathologist before proceeding with definitive treatment 6.
Treatment Strategy
For Symptomatic Lesions
Transurethral resection is the treatment of choice for symptomatic nephrogenic adenoma 3. The approach depends on lesion extent:
- Small, localized tumors: Endoscopic resection or fulguration 2, 4
- Larger polypoidal lesions: Transurethral resection provides good symptom relief 3
- Severe involvement of reconstructed urethra: May require open surgical correction with complete excision of the graft and urethral reconstruction 4
For Asymptomatic Lesions
Conservative management with surveillance and antibiotic therapy is acceptable for asymptomatic cases 7. This approach has shown patients remaining asymptomatic and recurrence-free during follow-up 7.
Critical Management Considerations
High Recurrence Risk
Recurrence rates are substantial - occurring in 23% of cases in one series 3, with particularly high rates in pediatric bladder cases 2. Urethral cases may have persistent symptoms suggesting continuing disease 2.
Mandatory Long-Term Surveillance
Long-term follow-up is essential for several reasons 5, 8:
- High recurrence rates documented across multiple studies
- Rare but reported potential for malignant transformation in adults 5, 8
- Need to monitor for symptom recurrence
Surveillance Protocol
Perform periodic cystoscopic examinations to detect recurrence early. The exact interval is not specified in guidelines, but given recurrence patterns, consider cystoscopy at 3-6 month intervals initially, then annually if stable.
Common Pitfalls to Avoid
Misdiagnosis as malignancy on frozen section - the variable morphology can mimic carcinoma 6. Always confirm with permanent sections and consider GU pathology consultation.
Inadequate resection - incomplete removal leads to recurrence. Ensure complete visual resection when technically feasible 1.
Failure to identify causative factors - address underlying irritative stimuli (remove catheters when possible, treat infections) to potentially reduce recurrence risk 3.
Premature discontinuation of surveillance - recurrences can occur years later, necessitating indefinite follow-up 5, 8.